COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 12, Pages e83801
Publisher
Public Library of Science (PLoS)
Online
2013-12-21
DOI
10.1371/journal.pone.0083801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin Attenuates Diet-Induced Hepatic Steatosis by Activating AMP-Activated Protein Kinase
- (2013) Min Young Um et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- AMP-activated protein kinase: A target for old drugs against diabetes and cancer
- (2013) Gian Luigi Russo et al. BIOCHEMICAL PHARMACOLOGY
- AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
- (2013) D. G. Hardie DIABETES
- Diabetes and cancer: two diseases with obesity as a common risk factor
- (2013) S. K. Garg et al. DIABETES OBESITY & METABOLISM
- Metabolic roles of AMPK and metformin in cancer cells
- (2013) Yeon Kyung Choi et al. MOLECULES AND CELLS
- Inflammation and metabolic dysfunction: links to cardiovascular diseases
- (2012) Annika Taube et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- 1,3-Bis(3,5-dichlorophenyl) urea compound ‘COH-SR4’ inhibits proliferation and activates apoptosis in melanoma
- (2012) Sharad S. Singhal et al. BIOCHEMICAL PHARMACOLOGY
- AMP-Activated Protein Kinase 1 Protects Against Diet-Induced Insulin Resistance and Obesity
- (2012) DIABETES
- AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity
- (2012) Joo-Won Lee et al. JOURNAL OF LIPID RESEARCH
- AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases
- (2012) Rai Ajit K. Srivastava et al. JOURNAL OF LIPID RESEARCH
- Sensing of energy and nutrients by AMP-activated protein kinase
- (2011) D Grahame Hardie AMERICAN JOURNAL OF CLINICAL NUTRITION
- The growing challenge of obesity and cancer: an inflammatory issue
- (2011) Alison E. Harvey et al. Annals of the New York Academy of Sciences
- AICAR response element binding protein (AREBP), a key modulator of hepatic glucose production regulated by AMPK in vivo
- (2011) Tomomi Shirai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression
- (2011) Hak-Su Kim et al. BIOCHEMICAL PHARMACOLOGY
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
- (2011) Yu Li et al. Cell Metabolism
- Novel dichlorophenyl urea compounds inhibit proliferation of human leukemia HL-60 cells by inducing cell cycle arrest, differentiation and apoptosis
- (2011) James L. Figarola et al. INVESTIGATIONAL NEW DRUGS
- AMP-activated protein kinase: nature's energy sensor
- (2011) David Carling et al. Nature Chemical Biology
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
- (2010) Simon A. Hawley et al. Cell Metabolism
- Resveratrol Modulates Tumor Cell Proliferation and Protein Translation via SIRT1-Dependent AMPK Activation
- (2010) Jia-Ni Lin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives
- (2009) B. Viollet et al. Acta Physiologica
- Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
- (2009) Woo Sik Kim et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
- (2009) S. Fogarty et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial
- (2009) D. K. Coletta et al. DIABETOLOGIA
- Rapamycin Protects Against High Fat Diet–Induced Obesity in C57BL/6J Mice
- (2009) Geng-Ruei Chang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth
- (2009) Junghyo Jo et al. PLoS Computational Biology
- Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
- (2008) Jing SHANG et al. ACTA PHARMACOLOGICA SINICA
- Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced Mitochondrial Respiration
- (2008) Pazit Polak et al. Cell Metabolism
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Fatty acid metabolism: target for metabolic syndrome
- (2008) Salih J. Wakil et al. JOURNAL OF LIPID RESEARCH
- Unknown
- (2008) Katja Rabe et al. MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started